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Abstract
HIV fusion and entry into CD4 T cells are mediated by two receptors, CD4 and CXCR4. This receptor requirement can be
abrogated by pseudotyping the virion with the vesicular stomatitis virus glycoprotein (VSV-G) that mediates viral entry
through endocytosis. The VSV-G-pseudotyped HIV is highly infectious for transformed cells, although the virus circumvents
the viral receptors and the actin cortex. In HIV infection, gp120 binding to the receptors also transduces signals. Recently,
we demonstrated a unique requirement for CXCR4 signaling in HIV latent infection of blood resting CD4 T cells. Thus, we
performed parallel studies in which the VSV-G-pseudotyped HIV was used to infect both transformed and resting T cells in
the absence of coreceptor signaling. Our results indicate that in transformed T cells, the VSV-G-pseudotyping results in
lower viral DNA synthesis but a higher rate of nuclear migration. However, in resting CD4 T cells, only the HIV envelope-
mediated entry, but not the VSV-G-mediated endocytosis, can lead to viral DNA synthesis and nuclear migration. The viral
particles entering through the endocytotic pathway were destroyed within 1–2 days. These results indicate that the VSV-G-
mediated endocytotic pathway, although active in transformed cells, is defective and is not a pathway that can establish HIV
latent infection of primary resting T cells. Our results highlight the importance of the genuine HIV envelope and its signaling
capacity in the latent infection of blood resting T cells. These results also call for caution on the endocytotic entry model of
HIV-1, and on data interpretation where the VSV-G-pseudotyped HIV was used for identifying HIV restriction factors in
resting T cells.
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Introduction
Binding of the HIV envelope to its receptors, CD4 and the
chemokine coreceptor, CCR5 or CXCR4, triggers sequential
fusion and entry events [1,2,3,4]. Fusion is believed to occur
directly at the plasma membrane [5,6,7,8,9], but fusion in
endosomes has also been proposed recently [10]. It has been
known that HIV can enter cells through endocytosis, but the virion
particles entering through this pathway appear to be trapped and
subsequently destroyed [11,12]. This endosomal degradation can
be rescued either by blocking the acidification of the endosomal
compartments [11,12] or by pseudotyping the HIV virion with the
vesicular stomatitis virus glycoprotein (VSV-G) [13,14]. The VSV-
G-pseudotyped HIV escapes from endosomes and is highly
infectious, giving the virus 20- to 130-fold higher infectivity
[15,16]. The ease of producing high-titer virus through VSV-G
pseudotyping has made the method very popular for manufactur-
ing viral stock used for gene delivery, drug screening, and the
identification of cellular genes and factors involved in HIV
replication [13,17,18,19].
Nevertheless, the VSV-G-pseudotyped viruses are not identical
to the genuine HIV particles. For example, the HIV Nef protein, a
critical factor involved in viral pathogenesis [20], no longer plays
an important role in the infection by the VSV-G-pseudotyped
virus [15]. Nef has been known to enhance viral infectivity by a
factor of 4 to 40 [21,22]. This positive effect of Nef on viral
infectivity appears to be at an early step post entry, such as
uncoating or reverse transcription [23,24,25]. Nef itself does not
directly affect reverse transcription, since Nef-defective virions
display normal levels of endogenous reverse transcriptase activity
[25]. It is likely that this early activity of Nef is connected to
cortical actin in some way. For example, when cells were treated
with actin inhibitors, the effect of Nef on viral replication was lost
[26]. This is also consistent with the fact that the VSV-G-
pseudotyped virus circumvents the cortical actin; thus, the impact
of Nef on viral infectivity is forfeited most likely because of the lack
of interaction with the actin cortex [15].
The VSV-G-pseudotyped HIV also does not engage CD4 and
CCR5 or CXCR4, and is deprived of the ability to transduce
signals through these receptors [27,28,29]. These intracellular
signaling cascades, particularly those transduced from the
chemokine coreceptors, have been suggested to be unnecessary
for viral fusion, entry, or the subsequent steps of viral replication in
transformed cell lines [30,31,32,33,34,35,36,37,38,39]. However,
recently, several reports have suggested a requirement for CD4
receptor signaling to mediate viral fusion and entry [40,41,42,43].
We have also observed an absolute requirement for CXCR4
signaling in HIV-1 latent infection of resting CD4 T cells [44] and
demonstrated that HIV-1 relies on viral envelope and the Gai-
dependent signaling from CXCR4 to activate a cellular actin-
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for viral intracellular migration [44]. Given that the VSV-G-
pseudotyped HIV infects cells in the absence of receptor signaling,
we performed parallel studies in which the VSV-G-pseudotyped HIV
was used to infect both transformed and resting CD4 T cells to
understand possible alternative pathways that the VSV-G-pseudotyped
HIV-1 may employ to establish latent infection of resting CD4 T cells.
Surprisingly, the VSV-G-pseudotyped HIV-1 exhibited a highly
diminished ability to initiate viral DNA synthesis and nuclear migration
in resting T cells, which is in striking contrast to the high efficiency of
VSV-G to mediate HIV infection of transformed cells. The viral
particles entering through the endocytotic pathway were destroyed
within 1–2 days in resting T cells. These results indicate that the VSV-
G-mediated endocytotic pathway, although active in transformed T
cells, is defective and not a pathway that can establish HIV latent
infection of primary CD4 T cells. These results highlight the
importance of the genuine HIV envelope and its signaling capacity
in the latent infection of primary resting T cells.
Results
Characterization of the VSV-G-pseudotyped HIV
replication in transformed T cells
We compared the infectivity of HIV-1 carrying either the HIV
envelope (Wt) or the VSV glycoprotein (VSV-G). Both viruses
were produced in parallel using the same cell culture and
transfection conditions (Figure 1A). Following harvesting of viral
particles, an equal p24 level of both viruses was used to infect a
transformed T cell line, CEM-SS. Viral replication was monitored
by p24 release. As shown in Figure 1B, we observed faster and
stronger replication of the VSV-G- pseudotyped virus, which
reached a level approximately 30 fold higher (at 48 hours) than the
wild-type HIV-1. Our result was consistent with previous reports
showing that the VSV-G-pseudotyped virus was 20 to 130 times
more infectious than wild-type HIV-1 [15,16]. It is likely that
without the limitation of HIV receptors, much more productive
viral entry may occur through the VSV-G-mediated endocytosis,
resulting in a much higher level of viral replication. In addition,
the faster replication kinetics of the VSV-G-pseudotyped virus is
likely a result of faster entry and nuclear migration.
We also compared viral early processes after entry by following
viral DNA synthesis and nuclear migration. We infected cells using
an equal TCID50 dosage instead of an equal p24. Although more
Wt particles were used (based on p24), infection with an equal
TCID50 ensured that the productive viral processes such as viral
DNA synthesis and nuclear migration would occur at comparable
levels within the viral population in each case. The TCID50 of
both viruses was measured on a Rev-dependent indicator cell,
Rev-CEM, as previously described [45]. As shown in Figure 2, at
2 hours post infection, viral DNA synthesis was measured, and the
VSV-G-pseudotyped HIV synthesized only approximately 20% of
viral DNA in comparison with the wild-type virus (Figure 2A),
probably either because fewer of the VSV-G-pseudotyped
particles enter the cells or because these particles are less efficient
at mediating viral DNA synthesis. We also followed viral nuclear
migration at later time points using viral 2-LTR circles as a
surrogate. As shown in Figure 2B, the VSV-G-pseudotyped virus
produced slightly more 2-LTR circles than the wild-type HIV-1,
Figure 1. Replication of HIV-1 carrying either VSV-G or the HIV
envelope in a transformed T cell, CEM-SS. (A) DNA constructs
used to generate VSV-G-pseudotyped and HIV-1 Env-typed HIV-1.
Viruses were generated by cotransfection and harvested at 48 hours. (B)
An equal p24 level (260 ng) of HIV-1(VSV-G) or HIV-1(Env) was used to
infect 1610
6 cells. Following infection for 2 hours, cell-free viruses were
washed away and cells were continuously incubated for 3 days. Viral
replication was monitored by p24 release.
doi:10.1371/journal.ppat.1000633.g001
Author Summary
While receptor-mediated viral endocytosis or fusion with
the cell membrane can be achieved through multiple
surface molecules, the repetitious selection of two
chemokine receptors, CCR5 or CXCR4, as the main HIV
entry coreceptor implies an urgent viral need to exploit
the chemotactic process in the immune system. Cytoskel-
etal rearrangement and cell migration are the primary
consequences of chemotactic signaling. Nevertheless,
previously published data demonstrated that depriving
the virus of its signaling ability conferred higher infectivity
through VSV-G-mediated endocytotic entry in transformed
cells. We revisited the issue of chemokine coreceptor
signaling and the role of cortical actin in HIV-1 latent
infection of resting CD4 T cells, in which the virus can
establish latency with a potential for productive replication
upon T cell activation. Our results confirmed that only the
genuine HIV-1 envelope protein, but not VSV-G, is capable
of mediating latent infection of resting CD4 T cells. These
findings highlight the importance of the HIV envelope and
its signaling capacity in HIV infection of its natural target
cells.
Gp120 versus VSV-G in HIV-1 Infection
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approximately 7 times higher in the VSV-G-mediated infection
(Figure 2C). These data suggest that in transformed T cells, the
VSV-G-mediated endocytotic entry is much more efficient in
delivering viral DNA into the nucleus. Even with a lower amount
of viral DNA synthesized initially, a higher percentage of these
DNA molecules entered the nucleus. On the other hand, in the
wild-type infection, even with more viral DNA synthesis, a lower
percentage of viral DNA molecules can enter the nucleus. These
results are consistent with a model [46] in which the cortical actin
plays an important role in viral reverse transcription [47], but the
actin cortex also serves as a natural barrier for viral intracellular
migration [44].
Inability of the VSV-G-pseudotyped HIV-1 to establish
latent infection of resting CD4 T cells
In contrast to the VSV-G-mediated endocytotic entry, the HIV
envelope-mediated fusion and entry requires specific interaction
withCD4and thechemokinecoreceptor,CCR5 orCXCR4.These
receptors not only mediate fusion but also transduce signals upon
gp120 binding[27,48,49]. Inparticular, signalstransduced from the
chemokine coreceptor CXCR4 have recently been shown to be
essential for HIV-1 latent infection of resting CD4 T cells [44].
Thus, we examined the ability of VSV-G-pseudotyped HIV-1 to
establish latent infection of resting CD4 T cells in the absence of
HIV coreceptor signaling. Resting CD4 T cells were purified from
the peripheral blood of healthy donors by negative depletion
(Figure 3A). Cells were rested overnight, and then infected with an
equal p24 level of the VSV-G-pseudotyped HIV-1 or the wild-type
HIV-1. Following infection, cells were washed and incubated for 5
days in the absence of T cell activation. During this incubation,
productive viral replication does not occur. However, viral
replication remains inducible upon T cell activation [44]. As a
control, cells were also pre-activated for 1 day with antibody
stimulation of the CD3/CD28 receptors (Figure 3B) and then
identically infected. As shown in Figure 3C, in CD3/CD28 pre-
activated T cells, productive viral replication occurred, and the
VSV-G-pseudotyped viral replication was approximately 10-fold
greater (48 h.p.i) than that of the wild-type virus. This is similar to
the VSV-G-pseudotyped viral replication in transformed T cells
(Figure 1). However, in latently infected resting CD4 T cells, when
cells were activated at day 5 post infection, only the wild-type virus
but not the VSV-G-pseudotyped HIV-1 was induced to replicate
(Figure 3D). This was strikingly different from the 10 to 30-fold
higher replication capacity of the VSV-G-pseudotyped virus in pre-
activated and transformed T cells (Figure 1 and Figure 3C). These
results were repeated using CD4 T cells from another donor with
AZT added to limit viral replication to a single cycle (Figure 3E and
3F). Reproducibly, only the wild-type virus but not the VSV-G-
pseudotyped virus was able to replicate following activation of
resting T cells at day 5 (Figure 3F), even though the VSV-G-
pseudotyped virus replicated to a 30-fold higher level (48h.p.i) in
pre-activated T cells (Figure 3E).
Inability of the VSV-G-pseudotyped HIV-1 to support viral
DNA synthesis and nuclear migration in resting CD4 T
cells
We followed the steps for viral infection of resting T cells. Using
a sensitive Nef-luciferase-based entry assay [50], we detected Wt
viral entry into both resting and activated T cells (Figure 4A),
although the entry into resting T cells was significantly lower.
However, we could not detect viral entry into both resting and
activated T cells in the VSV-G-pseudotyped virus infection,
although we detected the entry of the VSV-G-pseudotyped virus
into CEM-SS cells using the identical infection condition
(Figure 4A). Since the VSV-G-pseudotyped HIV-1 can replicate
in activated T cells (Figure 4C and 4E), these results suggested that
the Nef-luciferase-based entry assay may not have the sensitivity to
measure the VSV-G-mediated entry in primary T cells, either
resting or activated. Thus, we used an alternative method to detect
viral entry by measuring intracellular p24 following infection. Cells
were infected for 2 hours, trypsinized, washed, and then lysed for
Figure 2. Comparison of viral DNA synthesis in CEM-SS cells infected with either HIV-1(VSV-G) or HIV-1NL4-3. Cells were infected with
an equal TCID50 dose of HIV-1(VSV-G) or HIV-1NL4-3 (Wt) (1.27610
5 TCID50/Rev-CEM per million cells). Following infection for 2 hours, cell-free viruses
were washed away. Total cellular DNA was extracted from cells, and then amplified by real-time PCR to measure the synthesis of full-length HIV-1
DNA (2 hours post infection) (A) and 2-LTR circles at later time points (6 and 12 hours post infection) (B). The relative ratios of 2-LTR circles at
12 hours and HIV-1 DNA at 2 hours were plotted (C).
doi:10.1371/journal.ppat.1000633.g002
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comparable level of intracellular p24 in resting T cells infected
with the wild-type or the VSV-G-pseudotyped HIV-1. We also
observed a higher level of intracellular p24 in HIV-1(VSV-G)-
infected active T cells (Figure 4B). These results suggested that
entry of virion particles was similar in resting T cells infected with
the wild-type HIV-1 or HIV-1(VSV-G).
We then followed the course of viral DNA synthesis and nuclear
migration in resting CD4 T cells after infection. Unstimulated
resting CD4 T cells from another donor were infected with an
equal TCID50 dose of the VSV-G-pseudotyped HIV-1 or the
wild-type virus. After washing away free viruses at 2 hours post
infection, cells were continuously incubated without activation for
5 days, and then activated at day 5 with CD3/CD28 stimulation
Figure 3. The HIV envelope but not VSV-G is capable of mediating latent infection of resting CD4 T cells. Resting CD4 T cells were
purified from the peripheral blood by negative depletion. Cells were unstimulated (A) or activated with magnetic beads conjugated with antibodies
against the human CD3 and CD28 receptors (two beads per cell) for 1 day (B), and then analyzed for cell cycle progression using 7-AAD, PY staining to
confirm sufficient T cell activation following stimulation. (C) In CD3/CD28 pre-stimulated CD4 T cells, a higher than Wt level of viral replication was
observed in cells infected with HIV-1(VSV-G). One million cells were infected with 25 ng (p24) of HIV-1NL4-3 (wt) or the VSV-G pseudotyped virus (VSV-
G). (D) In resting CD4 T cells that were not pre-stimulated, only the Wt but not the VSV-G pseudotyped HIV-1 replicated following T cell activation at
day 5. Cells were infected with 25 ng (p24) of both viruses, incubated for 5 days, and then activated with anti-CD3/CD28 beads. (E) and (F) were a
repeat of (C) and (D) in another donor, with AZT (50 mM) added at day 1 and day 5 post infection, respectively, to limit viral replication to a single
cycle.
doi:10.1371/journal.ppat.1000633.g003
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activated (CD3/CD28 beads, two beads per cell) CD4 T cells (1610
6) were infected with 200 ng of Nef-luciferase-tagged HIV-1NL4-3 (Wt) or HIV-1(VSV-
G) for 2 hours. Infected cells were washed three times and then used to measure luciferase activity in live cells. As a control, CEM-SS cells were
identically infected with the Nef-luciferase-tagged HIV-1(VSV-G). Uninfected cells were identically treated and measured for luciferase activities. (B)
Resting or pre-activated (overnight PHA plus IL-2 treatment) CD4 T cells (1610
6) were infected with 200 ng of HIV-1NL4-3 (Wt) or HIV-1(VSV-G) in
0.5 ml for 2 hours. Following infection, cells were treated with TrypLE (Invitrogen) for 2 minutes at 37uC and then washed an additional three times
with medium. Cells were pelleted and subsequently lysed for p24 ELISA. (C to E) Resting CD4 T cells were infected with an equal TCID50 dose of HIV-
1NL4-3 (Wt) or HIV-1(VSV-G) (2.53610
5 TCID50/Rev-CEM per million cells). Following infection for 2 hours, cell-free viruses were washed away. Cells were
cultured for 5 days and then activated with anti-CD3/CD28 beads. (C) A measurement of p24 release confirmed that only the Wt virus but not HIV-
1(VSV-G) replicated following CD3/CD28 stimulation. (D, E) Total cellular DNA from infected cells was extracted at different time points, and then
amplified with real-time PCR for HIV late DNA (D) or 2-LTR-circles (E). (F, G) is a repeat of (D, E) on another donor using an equal p24 level of Wt and
HIV-1(VSV-G) to infect resting T cells. Total cellular DNA was extracted from infected cells at different time points and PCR-amplified for HIV late DNA
(F) or 1-LTR circles (G), along with the b-actin pseudogene as a control.
doi:10.1371/journal.ppat.1000633.g004
Gp120 versus VSV-G in HIV-1 Infection
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was analyzed, we did not observe viral DNA synthesis above the
initial background (Figure 4D) in cells infected with the VSV-G-
pseudotyped virus at any time point post infection, whereas in cells
infected with the wild-type virus, we observed the typical course of
viral DNA synthesis in which viral DNA synthesis proceeds slowly
and usually peaks at day 2, recedes at day 3, and then increases
again following T cell activation [44]. When viral 2-LTR circles
were measured, in cells infected with the VSV-G-pseudotyped
virus, we also could not detect 2-LTR circles at any time point,
even after CD3/CD28 stimulation at day 5, whereas in cells
infected with the wild-type virus, 2-LTR circles were detected and
the copy number increased with time (Figure 4E). We repeated
these experiments using resting CD4 T cells from another donor.
This time, resting cells were infected with an equal p24 level of
both viruses. We observed similar results. As shown in Figure 4F,
in cells infected with the VSV-G-pseudotyped virus, the initial
viral DNA detected (0.1 to 0.5 day in Figure 4F) diminished with
time, and no 1-LTR circles can be detected at any time point post
infection, whereas in the wild-type infected cells, the syntheses of
both viral DNA and 1-LTR circles were obvious (Figure 4F and
4G). Based on these results, we concluded that in resting CD4 T
cells, only the HIV envelope-mediated entry but not the VSV-G-
mediated endocytosis can lead to viral DNA synthesis and nuclear
migration, which are a prerequisite for the establishment of HIV
latent infection of resting CD4 T cells [44].
Decay of the VSV-G-pseudotyped HIV-1 in resting CD4 T
cells
We also measured the decay kinetics of the VSV-G-pseudo-
typed HIV-1 in resting CD4 T cells. Unstimulated resting CD4 T
cells were infected with an equal p24 level of both viruses.
Following infection for 2 hours, cell-free viruses were washed
away. Infected cells were then activated immediately or activated
at day 1, 3, or 5 post infection. As a control, resting cells were also
pre-activated with CD3/CD28 for 1 hour and then identically
infected. As shown in Figure 5, in CD3/CD28 pre-activated CD4
T cells, both the VSV-G-pseudotyped HIV-1 and the wild-type
virus replicated after infection (Figure 5A1 and 5B1). In resting T
cells, when cells were activated immediately after infection and
washing (2 hours post infection), viral replication was also initiated
from both the VSV-G- pseudotyped HIV-1 and the wild-type
virus (Figure 5A2 and 5B2). These results suggest that entry of the
VSV-G-pseudotyped virus into resting T cells occurs, and viral
replication can be rescued if cells are activated immediately.
However, when resting cells were left unactivated, after 1 day, the
replication of the VSV-G- pseudotyped virus following activation
was greatly diminished (Figure 5A3), and no viral replication could
be initiated after 3 days (Figure 5A4 and 5A5). This was in great
contrast to the wild-type HIV infection of resting T cells, in which
the capacity of HIV to replicate following activation increased
with time (Figure 5B1 to 5B5). The highest viral replication
occurred after 5 days of incubation. These data, in combination
with the results in Figure 4, suggest that in resting CD4 T cells, the
VSV-G-mediated endocytotic entry does not lead to a productive
pathway, and the viral particles are trapped in cells and
subsequently destroyed within 1–2 days. Our data are also
consistent with a previous study demonstrating that the VSV-G-
pseudotypedHIV-1hasahalf-life ofonly1–2daysinresting CD4T
cells [51]. The increasing ability of the wild-type HIV-1 to replicate
following incubation has also been observed previously [52,53,54].
Although HIV does not directly replicate in resting CD4 T cells, the
viral envelope-mediated entry establishes an active process that
enhances the ability of HIV to replicate following T cell activation.
This capacity has been attributed to the synthesis of Nef, which
lowers the threshold required for the activation of resting CD4 T
cells [52,53,54,55,56]. Certainly, our data confirmed these previous
findings and further indicated that only the genuine HIV envelope
protein but not the VSV-G can deliver the virus into the nucleus,
where the subsequent action of Nef can occur.
Differential inhibition of HIV-1 and the VSV-G-
pseudotyped HIV-1 by dynasore
In contrast to resting T cells, in transformed cell lines, the VSV-
G-mediated entry is very efficient in mediating HIV infection.
This fact has prompted a major argument that HIV may
predominately fuse in the endosome rather than at the plasma
membrane [10]. Microscopic imaging tracking the behaviors of
the majority of MLV particles suggested that the HIV-1 envelope-
pseudotyped virus entered cells predominantly through endocyto-
sis [10]. Indeed, dynasore, a dynamin-dependent endosomal
scission inhibitor, was shown to inhibit viral replication [10],
supporting the model that the endosomal fusion is associated with
a productive pathway. Nevertheless, this mode of entry is in
conflict with numerous previous observations suggesting that
genuine HIV envelope-associated endocytotic entry, although
occurring at a significant scale, does not naturally lead to
productive infection [5,6,7,9,11,12]. For example, inhibition of
the endosomal/lysosomal functionality can spare HIV from
degradation and enhance viral replication [11,12], demonstrating
that the endosomal viruses are normally directed for degradation.
In addition, the rate of CD4 or CCR5 endocytosis does not appear
to affect viral entry or replication [6,8,9], supporting direct viral
fusion at the plasma membrane. Nevertheless, the endocytosis
entry as proposed [10] is an attractive alternative pathway. If
proven biologically, it would require significant remodeling of the
role of the cortical actin in viral entry and early post-entry steps.
The involvement of the cortical actin in early endocytosis is largely
limited to membrane scission of clathrin-coated pits [57]. This
process does not involve direct contact between the cortical actin
and the viral particles. If there is any viral contact with actin, it
would be in the cytoplasm following endosomal fusion. This
interaction may also affect reverse transcription and nuclear
migration, but such effects would occur at different levels. The
issue of entry is so critical in the understanding of the role of the
cortical actin in HIV biology that we felt compelled to revisit some
of the key biological evidence - in particular, the inhibition of HIV
replication by the dynamin-dependent endosomal fusion inhibitor,
dynasore. Dynamins are a group of fundamental proteins involved
in multiple cellular processes such as vesicle transport, cytokinesis,
organelle division and cell signaling (for a review, see [58]). To
minimize possible cytotoxicity from prolonged inhibition of
fundamental cellular proteins, we treated cells only briefly with
dynasore during viral infection. Viruses that failed to enter were
subsequently washed away along with the drug. We also used the
Rev-dependent indicator cell, Rev-CEM [45], to measure
dynasore inhibition, instead of simply using p24 ELISA, which
by itself is not capable of distinguishing between HIV-specific
inhibition and general drug cytotoxicity. Additional advantages of
using Rev-CEM are its high specificity and the ability to
distinguish subpopulations of cells by flow cytometry so that
non-specific cytotoxicity can be excluded [59]. As shown in
Figure 6A, we first tested dynasore in the inhibition of the VSV-G-
pseudotyped HIV-1 replication and observed dosage-dependent
inhibition of viral replication. At 80 mM, dynasore moderately
decreased the GFP+ population from 16.1% to 11.5%; at 8 mM,
dynasore also slightly decreased the GFP+ population; at 0.8 mM,
dynasore minimally affected viral infection. However, when
Gp120 versus VSV-G in HIV-1 Infection
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with HIV-1, we did not observe similar dosage-dependent
inhibition. Even at 80 mM, dynasore minimally affected HIV-1
infection (Figure 6B). These results demonstrate a clear distinction
between the VSV-G-mediated endocytotic entry and the HIV-1-
envelope-mediated entry in mediating productive viral replication.
Figure 5. Decay of the VSV-G-pseudotyped HIV-1 in resting CD4 T cells. (A) Resting CD4 T cells were purified by negative depletion, rested
overnight, and then pre-stimulated with anti-CD3/CD28 beads for 1 hour and infected with HIV-1(VSV-G) (552 ng p24 per million cells) (A1). Cells
were also infected without pre-stimulation (A2 to A5) and then stimulated with anti-CD3/CD28 beads at 2 hours, day 1, day 3, or day 5 post infection
to initiate viral replication. The p24 release was measured following anti-CD3/CD28 stimulation (marked as day ‘‘0’’ on the X-axis of each panel). (B)i s
a repeat of (A) in the same donor, using HIV-1NL4-3 (Wt) (552 ng p24 per million cells).
doi:10.1371/journal.ppat.1000633.g005
Gp120 versus VSV-G in HIV-1 Infection
PLoS Pathogens | www.plospathogens.org 7 October 2009 | Volume 5 | Issue 10 | e1000633Discussion
In this report, we demonstrated a fundamental difference
between the HIV-1 envelope and VSV-G in mediating HIV-1
latent infection of primary resting CD4 T cells, namely that only
the HIV-1 envelope but not VSV-G is capable of supporting HIV
latent infection of resting T cells. The block to the VSV-G-
pseudotyped virus in resting T cells was most obvious at post-entry
steps such as viral DNA synthesis and nuclear migration. The
virion particles trapped in cells were subsequently destroyed within
1–2 days in resting T cells. These results demonstrated the
importance of the genuine HIV envelope in mediating latent
infection of resting T cells.
Previously, we demonstrated a critical function of the HIV-1
envelope in mediating CXCR4 signaling and promoting the
cortical actin dynamics necessary for HIV latent infection of
resting T cells [44]. We also proposed a dual function of F-actin in
which the actin cortex serves as an anchorage for reverse
transcription and as a vehicle for the delivery of the preintegration
complex across the cortical actin through actin treadmilling
Figure 6. Different effects of dynasore on the replication of HIV-1(VSV-G) and Wt in a human T cell, Rev-CEM. (A) Rev-CEM, a Rev-
dependent GFP indicator cell, was pretreated for 30 minutes with 80 mM, 8 mM, or 0.8 mM dynasore, respectively, or treated with 0.1% DMSO as a
control. Cells were subsequently infected with HIV-1(VSV-G) in the presence of dynasore for 2 hours. Following infection, cells were washed three
times with medium, and then cultured in the absence of dynasore. Viral replication was monitored by flow cytometry analysis of HIV-dependent GFP
expression at 48 hours (20,000 cells analyzed per sample). Propidum iodide (PI) was added into the cell suspension prior to flow cytometry. Viable
cells were gated (R1) based on low PI staining and cell size (FSC). GFP expression within the viable cell population (R1) was measured. Both the GFP
percentage (%) and mean intensity (M) were shown. (B) is an identical experiment using HIV-1NL4-3 (Wt). For the 80 mM dynasore treatment, another
three-independent infections with each virus were performed. The averages from the three-independent experiments are: 15.05%60.21 (VSV-G),
10.11%60.06 (VSV-G plus 80 mM dynasore), p=0.0003; 2.94%60.39 (Wt), 2.84%60.30 (Wt plus 80 mM dynasore), p=0.38.
doi:10.1371/journal.ppat.1000633.g006
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are known to interact with actin; the viral nuclear capsid
[60,61,62,63], the large subunit of the reverse transcriptase [64],
the integrase [65], and Nef [66]. We have also shown that blocking
actin polymerization with Jasplakinolid (120 nM) or Latrunculin A
(2.5 mM) inhibits viral DNA synthesis or HIV latent infection.
Conversely, triggering actin polymerization through cofilin
shRNA knockdown enhances viral DNA synthesis [44]. These
previous results and other studies [47] are consistent with the
findings in this study, in which the VSV-G-mediated entry that
bypasses the cortical actin led to less viral DNA synthesis in
transformed cells (Figure 2). The VSV-G-pseudotyping also
resulted in a lack of the slow viral DNA synthesis that is normally
seen in HIV-1 latent infection of resting T cells (Figure 4D and
4F). Viral nuclear DNA was also completely missing in the VSV-
G-mediated entry in resting cells (Figure 4E and 4G). These results
suggest that the VSV-G-pseudotyped particles may be delivered to
a different cytoplasmic location and enter the nucleus by a
different route, one that is normally highly effective in transformed
or metabolically active cells but defective in resting T cells.
Our results are consistent with a recent independent study
demonstrating that only the CXCR4-tropic HIV-1 envelope but
not VSV-G can support lentiviral vectors to deliver genes into
resting CD4 T cells [67]. In this study, Agosto and co-authors also
found that viral DNA synthesis was greatly diminished in resting
CD4 T cells infected with the VSV-G-pseudotyped lentiviral
particles. Nevertheless, the limitation on viral infection was
specifically attributed to the lack of viral entry and fusion in the
VSV-G-mediated infection of resting T cells [67]. Our results
suggested that the restriction was likely at an unknown post-entry
step such as endosomal fusion, uncoating, or reverse transcription.
The discrepancy in conclusions arises from different explanations
of the data acquired from entry and fusion assays. Both Agosto
and co-authors [67] and we observed an absolute lack of entry
signals in HIV-1(VSV-G)-infected resting T cells, using two
different entry assays. However, these assays, particularly the
BlaM-Vpr-based fusion assay [68] may not be appropriate for the
measurement of VSV-G-mediated fusion in resting T cells. It is
possible that if the VSV-G-pseudotyped virus is trapped in a
compartment, or is going through a degradation process with a
half-life of only 1 day [51], the BlaM substrate which takes about
12–18 hours to load may not be able to access or sufficiently react
with the enzyme. Given this lack of mechanistic clarity of how
these enzyme-tagged particles are delivered through VSV-G in
resting T cells, we did not feel confident that conclusions can be
drawn based on a fusion assay. Thus, we drew our conclusions
relying on multiple results. Firstly, we detected a comparable
intracellular p24 level in resting T cells infected with Wt or HIV-
1(VSV-G) (Figure 4B). Secondly, the VSV-G-pseudotyped virus
can be partially rescued if resting T cells were activated within 1
day of infection, indicating some viral entry into the cells
(Figure 5A2). Thirdly, low levels of viral DNA were also detected
at early time (2 hours, Figure 4F), indicating again that there were
some levels of entry. Given that the VSV-G-pseudotyped viruses
are 20 to 130-fold more infectious than the wild-type HIV-1, these
initial viral activities should give rise to a measurable level of viral
replication, but they did not.
The failure of the VSV-G-mediated entry to establish latent
infection of resting T cells is not currently understood. It is possible
that the cellular environment in resting T cells may not permit
viral fusion in endosomes. Alternatively, successful endosomal
fusion may occur, but the quick delivery of viral particles into the
cytosol may be detrimental [69], likely due to the possible
restrictive environment of resting cells [17,70] or a lack of cytosolic
factors for uncoating [71] DNA synthesis, or nuclear localization.
Our attempts to rescue the VSV-G-pseudotyped virus by changing
the intracellular PH were not successful (data not shown). Pre-
stimulation of the CD4 and CXCR4 receptors with gp120 or
antibodies also could not rescue the VSV-G-pseudotyped virus in
resting T cells (data not shown), although these pre-stimulations
enhanced the wild-type HIV replication several fold following T
cell activation [44]. These results are consistent with the fact that
the positive benefits of viral receptor signaling are only associated
with gp120-mediated entry but not with the VSV-G-mediated
endocytosis that circumvents the cortical actin.
The high efficiency of VSV-G to mediate endosomal escape and
HIV replication in transformed cells has led to the misconception
that the VSV-G-pseudotyped HIV should be as effective as the
wild-type HIV for latent infection of resting T cells [72,73].
Several previous studies have also used the VSV-G-pseudotyped
virus to identify restriction factors in resting T cells [17,74]. Our
results suggest that these data need to be interpreted cautiously.
Apparently, the VSV-G-mediated entry does not experience the
same intracellular environment as HIV does, and cannot lead to
the establishment of latent infection in resting T cells. Thus, those
previously identified cytoplasmic restriction factors may or may
not directly affect HIV infection. Interestingly, a recent imaging
study demonstrated a direct dependence of active viral nuclear
migration on F-actin, since actin inhibitors diminished the nuclear
concentration of the preintegration complex (PIC) (Dr. Thomas
Hope, personal communication). This study raises the possibility
that PIC may be associated with F-actin up to the nucleus [75,76].
Given that viruses usually use F-actin for short-distance travel, and
the cytoplasmic space between the cortical actin and the nucleus is
relatively thin in T cells, it is possible that the cytosolic exposure of
PIC in T cells is minimal.
Materials and Methods
Ethics statement
All protocols involving human subjects were reviewed and
approved by the GMU IRB. Informed written consents from the
human subjects were obtained in this study.
Plasmids and DNA cloning
Plasmid pNL4-3 was kindly provided by Dr. Malcolm Martin
[77]. The env mutant, pNL4-3(KFS), was kindly provided by Dr.
Eric Freed [78]. pHCMV-G that expresses the vesicular stomatitis
virus glycoprotein has been described previously [79]. pNLDYEnv
was constructed by inserting the env gene of HIV-1NL4-3 into the
lentiviral vector pNL-RRE-SA [80]. The packaging signal was
further deleted by cutting with KasI plus BssHII and re-ligating.
Viruses and cells
HIV-1NL4-3 was generated by transfection of plasmid pNL4-3
into HEK293T cells using lipofectamine 2000 (Invitrogen) as
described previously [80]. The VSV-G-pseudotyped virus, HIV-
1(VSV-G), was produced by cotransfection of HEK393T cells
(3610
6) with 10 mg of pHCMV-G and 10 mg of plasmid pNL4-
3(KFS). The HIV-1 envelope-typed virus, HIV-1(Env), was
produced by cotransfection of HEK293T cells with 10 mgo f
pNLDYEnv and 10 mg of pNL4-3(KFS). Viral supernatant was
harvested at 48 hours post cotransfection, centrifuged for
15 minutes at 5006g to remove cellular debris, filtered through
a 0.45 mm filter, treated with Benzonase (Novagen) (250 U/ml) at
37uC for 15 minutes, and then stored at -80uC. Levels of p24 in
viral supernatant were measured using the Perkin Elmer Alliance
p24 antigen ELISA Kit (Perkin Elmer). Plates were kinetically read
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ments) at 630 nm. Viral titer (TCID50) was determined on the
Rev-dependent GFP indicator cell, Rev-CEM [45,81]. CEM-SS
cells from Dr. Peter L. Nara [82] were obtained through the AIDS
Research and Reference Reagent Program, Division of AIDS,
NIAID, NIH. All cells were cultured in RPMI 1640 medium
supplemented with 10% heat-inactivated fetal bovine serum
(Invitrogen), penicillin (50 U/ml), and streptomycin (50 mg/ml).
Isolation, culturing, and infection of resting CD4 T cells
Peripheral blood mononuclear cells (PBMC) were obtained from
healthy donors at the Student Health Center, George Mason
University (GMU), Fairfax, VA. Resting CD4 T cells were purified
by two rounds of negative selection as previously described [54].
Purified cells were cultured in RPMI 1604 medium supplemented
with10% heat-inactivatedfetalbovine serum(Invitrogen), penicillin
(50 U/ml), and streptomycin (50 mg/ml) overnight before infection
or treatment.For activation of restingCD4 T cells with PHA (3 mg/
ml) (Sigma) plus IL-2 (100 U/ml) (Roche Applied Science), cells
were cultured in the presence of these agents for 12 hours. For
infection, CD4T cellswere incubated with the virus for2 hours and
then washed twice with medium to remove unbound virus. Infected
cells were resuspended in fresh RPMI 1604 medium supplemented
with 10% heat-inactivated fetal bovine serum at a density of 10
6 per
ml and incubated for 5 days without stimulation. Cells were
activated at day 5 with anti-CD3/CD28 magnetic beads at 4 beads
per cell. For the viral replication assay, 10% of infected cells were
taken at days 1, 3, 5, 6, 7, 8, and 9 post infection. Cells were pelleted
and the supernatant was saved for p24 ELISA.
CD3/CD28 bead conjugation and stimulation of resting
CD4 T cells
Monoclonal antibodies against human CD3 (clone UCHT1)
and CD28 (clone CD28.2) were purchased from BD Pharmingen
(BD Biosciences). For conjugation, antibodies were conjugated
with 4610
8 Dynal beads (Invitrogen) for 30 minutes at room
temperature. Free antibodies were washed away with PBS-0.5%
BSA. The conjugated magnetic beads were resuspended in 1 ml of
PBS-0.5% BSA. For stimulation of resting CD4 T cells, antibody-
conjugated beads were washed twice and then added to cell
culture and rocked for 5 minutes.
Cell cycle analysis by 7-AAD and PY staining
Resting CD4 T cells or CD3/CD28-stimulated cells (10
6) were
used for the analysis. Before staining, magnetic beads were
removed by incubating with DNase I releasing buffer as
recommended by the manufacturer. Cells were suspended in
1 ml of 0.03% saponin in PBS and then incubated in 20 mM7 -
amino-actinomycin D (Sigma) for 30 minutes at room tempera-
ture in the dark. Cells were kept on ice for at least 5 minutes,
pyronin Y (Sigma) was added to a final concentration of 5 mM,
and the cells were then incubated for 10 minutes on ice. Stained
cells were directly analyzed by flow cytometry on a FACS (Becton
Dickinson FACSCalibur).
Production of HIV-1 and VSV-G-pseudotyped HIV-1
containing Nef-luciferase fusion protein for entry assay
Plasmid pCDNA3-Nef-Luc was kindly provided by Dr. Robert
Davey [50]. Viruses containing Nef-luciferase was produced as
described previously [50]. Briefly, 293T cells cultured in a 10 cm
petri dish were cotransfected with 10 mg pNL4-3 plus 10 mgo f
pcDNA3-Nef-luc, or with 10 mg pNL4-3(KFS) plus 7.5 mg
pcDNA3-Nef-luc plus 2.5 mg pHCMV-G, using lipofectamine
2000 (Invitrogen) as recommended by the manufacturer. Viruses
were harvested at 48 hours post cotransfection and filtered
through a 0.45 mM filter. For entry assays, cells (1610
6) were
infected with 200 ng of Nef-luciferase containing viruses at 37uC
for 2 hours, and then washed three times with medium. Cells were
resuspended in 0.1 ml of luciferase assay buffer (Promega) and
luciferase activity was measured in live cells using a GloMax-Multi
Detection System (Promega).
PCR and Real-time PCR
Total cellular DNA was purified using the Wizard SV Genomic
DNA Purification System as recommended by the manufacturer
(Promega). The detection of viral late DNA and 1-LTR-circles by
PCR was performed as described previously [83]. Briefly, for viral
late DNA, forward primer: 59 GGTTAGACCAGATCT-
GAGCCTG 39 and reverse primer: 59 TTAATACC-
GACGCTCTCGCACC 39 were used. PCR was carried out in
16Ambion PCR buffer, 125 mM dNTP, 50 pmol each primer,
1 U SuperTaq Plus (Ambion) with 30 cycles at 94uC for
20 seconds, 68uC for 40 seconds. For detection of 1-LTR circle,
primers LTR-nef2 (59 TGGGTTTTCCAGTCACACCTCAG
39) and LTR-gag (59 GATTAACTGCGAATCGTTCTAGC 39)
were used. The reaction was carried out in 16Ambion PCR
buffer, 1.5 nM Mg
2+, 125 mM dNTP, 50 pmol each primer, 1 U
SuperTaq Plus (Ambion) with 35 cycles at 94uC for 20 seconds,
68uC for 90 seconds. Real-time PCR quantification of viral late
DNA and 2-LTR circles was also performed as described
previously [44,84], using 300 nM primers and 200 nM probes.
The DNA standard used for both late DNA and 2-LTR circle
quantification was constructed using a plasmid containing a
complete 2 LTR region (pLTR-2C); the plasmid was cloned by
amplification of infected cells with 59-TGGGTTTTCCAGTCA-
CACCTCAG-39 and 59-GATTAACTGCGAATCGTTC-
TAGC-39. Measurement was run in triplicate ranging from 1 to
10
6 copies of pLTR-2C mixed with DNA from uninfected cells.
Confocal microscopy
FITC-phalloidin staining of F-actin has been described
previously [44]. Stained cells were imaged using a Zeiss Laser
Scanning Microscope, LSM 510 META, with a 40 NA 1.3 or 60
NA 1.4 oil DIC Plan-Neofluar objective. Images were processed
and analyzed by LSM 510 META software.
Flow cytometry
Dynasore monohydrate (Sigma) was dissolved in DMSO.
Following dynasore treatment, infection, and washing, cells were
incubated for 48 hours, and then 500 ml cells were removed and
stained with 2 mg/ml propidium iodide solution (Fluka) for
5 minutes at room temperature. Following incubation, cells were
analyzed using the FACSCalibur (BD Biosciences). Data analysis
was performed using CellQuest (BD Biosciences).
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